Biel is Only-This-Low in Price for Two Reasons
Post# of 7796
(Total Views: 203)
Posted On: 03/08/2019 10:33:38 AM
Biel is Only-This-Low in Price for Two Reasons
1. Bayer Deal Fell through Because Bayer has Decided to put the Dr Scholls
Division up For Sale as they Hunker Down for Monsanto Lawsuits.
Bayer is selling several Divisions and cutting 10% of their work force.
Had this unfortunate circumstance not have occurred Biel would be in a good place right now.
Company is not waiting, the new product will be out shortly.
2. FDA conceded the Full Body Worked Well but , are you ready for this
"better for women than for men."
Not that it doesn't work for men just not as well.
They have refiled for women only and started trials for a man’s version of Actipatch.
The New 510K is in and could get a very Swift Clearance as all the homework has been done.
A second 510K has also been filed for RecoveryRX Wound Care.
Heals Wounds 50 to Nearly 72% Faster.
CVS Full Rollout and 2 510K's bye bye Penny.
1. Bayer Deal Fell through Because Bayer has Decided to put the Dr Scholls
Division up For Sale as they Hunker Down for Monsanto Lawsuits.
Bayer is selling several Divisions and cutting 10% of their work force.
Had this unfortunate circumstance not have occurred Biel would be in a good place right now.
Company is not waiting, the new product will be out shortly.
2. FDA conceded the Full Body Worked Well but , are you ready for this
"better for women than for men."
Not that it doesn't work for men just not as well.
They have refiled for women only and started trials for a man’s version of Actipatch.
The New 510K is in and could get a very Swift Clearance as all the homework has been done.
A second 510K has also been filed for RecoveryRX Wound Care.
Heals Wounds 50 to Nearly 72% Faster.
CVS Full Rollout and 2 510K's bye bye Penny.
(0)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼